Cleared Traditional

Hydrozid (K201740) - FDA 510(k) Clearance

Class II General & Plastic Surgery device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2021
Decision
377d
Days
Class 2
Risk

K201740 is an FDA 510(k) clearance for the Hydrozid. Classified as Unit, Cryosurgical, Accessories (product code GEH), Class II - Special Controls.

Submitted by Medilink A/S (Kgs. Lyngby, DK). The FDA issued a Cleared decision on July 7, 2021 after a review of 377 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4350 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Medilink A/S devices

Submission Details

510(k) Number K201740 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 25, 2020
Decision Date July 07, 2021
Days to Decision 377 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
262d slower than avg
Panel avg: 115d · This submission: 377d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GEH Unit, Cryosurgical, Accessories
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4350
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GEH Unit, Cryosurgical, Accessories

All 64
Devices cleared under the same product code (GEH) and FDA review panel - the closest regulatory comparables to K201740.
Urethral Warming Catheter Kit
K211149 · Varian Medical Systems, Inc. · Jan 2022
C2 CryoBalloon Ablation System
K212814 · Pentax of America, Inc. · Nov 2021
CryoDose V 50/50, 175ml Canister Kit, CryoDose V 50/50, 236ml Canister Kit
K210310 · Nuance Medical, LLC · Oct 2021
CryoVIVE
K203481 · Recensmedical, Inc. · May 2021
Dr. Yglo Wart Remover
K210529 · Theotclab Healthcare B.V. · May 2021
Forwarts
K201366 · Pronova Laboratories BV · Jan 2021